查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
局部藥物輸送的全球市場:各產品，各地區分析-預測(～2028年)
市場調查報告書
商品編碼
1064096

局部藥物輸送的全球市場:各產品，各地區分析-預測(～2028年)

Topical Drug Delivery Market Forecasts to 2028 - Global Analysis By Product (Liquid Formulations, Solid Formulations, Devices (Transdermal Drug Delivery), Semi-Solid Formulations), and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3個工作天內

價格

全球局部藥物輸送的市場規模在2021年估算為1,012億9,000萬美金，到2028年前將達到1,781億5,000萬美元，在預測期間內的年複合成長率預計將為8.4％。

本報告提供全球局部藥物輸送市場相關調查分析，提供促進因素，阻礙因素，給藥途徑·產品·流通管道·使用設施·類型·各地區市場分析，企業簡介等資訊。

目錄

第1章 摘要整理

第2章 序文

第3章 市場趨勢分析

  • 促進因素
  • 阻礙因素
  • 市場機會
  • 威脅
  • 產品分析
  • 新興市場
  • COVID-19影響

第4章 波特的五力分析

第5章 局部藥物輸送的全球市場:各給藥途徑

  • 陰道藥物輸送
  • 直腸藥物輸送
  • 眼科用藥物輸送
  • 鼻腔給藥
  • 皮膚藥物輸送

第6章 局部藥物輸送的全球市場:各產品

  • 液體製劑
    • 懸浮液
    • 溶液
  • 固態製劑
    • 栓劑
    • 粉狀體
  • 設備(經皮吸收型藥物輸送)
    • 經皮吸收型半固態劑
    • 經皮吸收型貼片
    • 吸入器
  • 半固態製劑
    • 粘貼
    • 軟膏
    • 化妝水
    • 凝膠
    • 乳霜

第7章 局部藥物輸送的全球市場:各流通管道

  • 零售
    • 離線
    • 線上
  • 直接競標

第8章 局部藥物輸送的全球市場:各使用設施

  • 醫院·民間診所
  • 居家照護的設定
  • 燒燙傷治療中心
  • 其他的設施
    • 學術·研究機關
    • 診斷中心

第9章 局部藥物輸送的全球市場:各類型

  • 硬質支架
  • 附鉸鏈支架
  • 軟質·伸縮性支架

第10章 局部藥物輸送的全球市場:各地區

  • 北美
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙
    • 其他歐洲
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 紐西蘭
    • 韓國
    • 其他亞太地區
  • 南美
    • 阿根廷
    • 巴西
    • 智利
    • 其他南美
  • 中東·非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 卡達
    • 南非
    • 其他中東·非洲

第11章 主要發展

  • 契約，夥伴關係，合作，合資企業
  • 收購與合併
  • 新產品的銷售
  • 事業擴大
  • 其他的主要策略

第12章 企業簡介

  • Teligent Pharma
  • Almirall, S.A
  • Perrigo Pharma
  • Novartis AG
  • Bayer AG
  • Mylan
  • Merck & Co
  • LEO Pharma
  • Johnson & Johnson
  • Agile Therapeutics Inc.
  • Cipla Ltd
  • GlaxoSmithKline
  • Encore Dermatology, Inc.
  • Crescita Therapeutics Inc.
  • Taro Pharmaceutical Industries Ltd
  • Bausch Health Companies
  • Glenmark Pharmaceuticals
  • Aclaris Therapeutics, Inc.
Product Code: SMRC21699

According to Stratistics MRC, the Global Topical Drug Delivery Market is accounted for $109.80 billion in 2022 and is expected to reach $178.15 billion by 2028 growing at a CAGR of 8.4% during the forecast period. Topical drug delivery refers to the delivery of drugs through topical routes such as the skin, mucosa, or cavities in the body. These are applied locally to avoid the first-pass effect of the drug or for site-specific action. A topical mode of delivery offers benefits such as site-specificity, eliminating fluctuations in the levels of drugs, improved suitability for self-medication, and better compliance.

The total global cell and gene drug delivery devices market was dominated by North America and Europe, which were responsible for than 83 percent of the market all together. It was forecast that this domination will continue until 2030, although the market share in the U.S. was projected to drop some four percent. It was estimated that 60 percent of drugs in the R&D pipeline were with an injectable delivery route, thus making it the top delivery route for drugs in pipeline.

Market Dynamics:

Driver:

Growing prevalence of skin diseases

Growing prevalence of skin disorders and infections including acne, psoriasis, and eczema, rising incidences of minor skin injuries such as skin burns, increasing self-medication practices, and increased consumer spending on dermatological products such as anti-acne and anti-septic creams and gels are among the other key factors expected to drive the global topical drug delivery market. As topical drug delivery is the first line of treatment for the majority of skin diseases, the demand for advanced topical products is expected to increase in the coming years.

Restraint:

Availability of alternative modes of drug delivery

There are several alternative drug delivery modes available for patients and end users. The benefits of these alternatives over topical drug delivery form a key restraint to the growth of this market. Of these, the oral route is the most preferred as it is easy to use, convenient, cost-effective, safe, and acceptable. Furthermore, orally administered drugs can be conveniently stored and are portable, economical, noninvasive, and safe.

Opportunity:

Delivery of biologics through the transdermal route

The delivery of biologics through the transdermal route is one of the emerging trends in the topical drug delivery market. The transdermal delivery of large molecules as an alternative to intramuscular, subcutaneous, or intravenous routes of administration is expected to provide significant patient benefits, such as painless drug delivery and cost-effective treatment.

Threat:

Technical barriers related to skin irritation

The chance for local adverse reactions and skin irritation is a significant challenge for topical drug delivery formulation and transdermal systems. However, the emergence of novel techniques for skin permeation and the development of methods to reduce skin irritation would help widen the topical drug delivery formulations and transdermal systems market for hydrophilic compounds, macromolecules, and conventional drugs for new therapeutic indications.

The home care settings segment is expected to be the largest during the forecast period

The home care settings segment is expected to be the largest during the forecast period owing to the convenience and affordability of topical drugs for home administration. Also, for patients requiring long-term therapy, inpatient care is not only extremely expensive but also prevents patients from resuming a normal lifestyle and work activities. In this regard, technological advancements have helped patients undergo therapies effectively and safely at home.

The dermal drug delivery (skin) segment is expected to have the highest CAGR during the forecast period

The dermal drug delivery segment is expected to witness the highest growth during the forecast period. This can be attributed to the advantages of dermal drug delivery over other topical drug delivery methods, such as convenience and greater patient compliance. Besides, dermal products have fewer regulatory requirements than ophthalmic products, where sterility testing is mandatory.

Region with largest share:

North America is projected to hold the largest market share owing to the growing product launches by various key players in the region. Due to the COVID-19 outbreak, the market is expecting to observe positive growth. This is mainly due to the novel treatment being developed. The growing burden of skin-related conditions is also expected to accelerate the market growth.

Region with highest CAGR:

Asia Pacific is projected to have the highest CAGR due to the high incidence of skin diseases (such as skin cancer), increasing use of contraceptives, and the growing focus of pharmaceutical companies on the R&D of smart transdermal drug delivery systems.

Key players in the market

Some of the key players profiled in the Topical Drug Delivery Market include Teligent Pharma, Almirall, S.A, Perrigo Pharma, Novartis AG, Bayer AG, Mylan, Merck & Co, LEO Pharma , Johnson & Johnson, Agile Therapeutics Inc., Cipla Ltd, GlaxoSmithKline, Encore Dermatology, Inc., Crescita Therapeutics Inc., Taro Pharmaceutical Industries Ltd, Bausch Health Companies, Glenmark Pharmaceuticals, and Aclaris Therapeutics, Inc.

Key developments:

In February 2021: Almirall and MC2 Therapeutics went under an exclusive agreement for the commercialization of its product 'Wynzora', a topical drug indicated against the treatment of plaque psoriasis.

In December 2020: Agile Therapeutics Inc. introduced Twirla (levonorgestrel and ethinyl estradiol) transdermal system, which is a contraceptive patch.

In August 2020: LEO Pharma received United States Food and Drug Administration approval for its delgocitinib cream for the treatment of moderate-to-severe chronic hand eczema (CHE) in adults.

In November 2018: Bausch Healthcare expanded its manufacturing facility in Rochester in order to support and fulfill the demand of its topical eye health products.

Routes of Administration Covered:

  • Vaginal Drug Delivery
  • Rectal Drug Delivery
  • Ophthalmic Drug Delivery
  • Nasal Drug Delivery
  • Dermal Drug Delivery (Skin)

Products Covered:

  • Liquid Formulations
  • Solid Formulations
  • Devices (Transdermal Drug Delivery)
  • Semi-Solid Formulations

Distribution Channels Covered:

  • Retail
  • Direct Tenders

Facilities of Use Covered:

  • Hospitals & Private Clinics
  • Home Care Settings
  • Burn Centers
  • Other Facilities

Types Covered:

  • Hard & Rigid Braces
  • Hinged Braces
  • Soft & Elastic Braces

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2020, 2021, 2022, 2025, and 2028
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 Emerging Markets
  • 3.8 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Topical Drug Delivery Market, By Route of Administration

  • 5.1 Introduction
  • 5.2 Vaginal Drug Delivery
  • 5.3 Rectal Drug Delivery
  • 5.4 Ophthalmic Drug Delivery
  • 5.5 Nasal Drug Delivery
  • 5.6 Dermal Drug Delivery (Skin)

6 Global Topical Drug Delivery Market, By Product

  • 6.1 Introduction
  • 6.2 Liquid Formulations
    • 6.2.1 Suspensions
    • 6.2.2 Solutions
  • 6.3 Solid Formulations
    • 6.3.1 Suppositories
    • 6.3.2 Powders
  • 6.4 Devices (Transdermal Drug Delivery)
    • 6.4.1 Transdermal Semi-solids
    • 6.4.2 Transdermal Patches
    • 6.4.3 Inhaler
  • 6.5 Semi-Solid Formulations
    • 6.5.1 Pastes
    • 6.5.2 Ointments
    • 6.5.3 Lotions
    • 6.5.4 Gels
    • 6.5.5 Creams

7 Global Topical Drug Delivery Market, By Distribution Channel

  • 7.1 Introduction
  • 7.2 Retail
    • 7.2.1 Offline
    • 7.2.2 Online
  • 7.3 Direct Tenders

8 Global Topical Drug Delivery Market, By Facility of Use

  • 8.1 Introduction
  • 8.2 Hospitals & Private Clinics
  • 8.3 Home Care Settings
  • 8.4 Burn Centers
  • 8.5 Other Facilities
    • 8.5.1 Academic & Research Institutes
    • 8.5.2 Diagnostic Centers

9 Global Topical Drug Delivery Market, By Type

  • 9.1 Introduction
  • 9.2 Hard & Rigid Braces
  • 9.3 Hinged Braces
  • 9.4 Soft & Elastic Braces

10 Global Topical Drug Delivery Market, By Geography

  • 10.1 Introduction
  • 10.2 North America
    • 10.2.1 US
    • 10.2.2 Canada
    • 10.2.3 Mexico
  • 10.3 Europe
    • 10.3.1 Germany
    • 10.3.2 UK
    • 10.3.3 Italy
    • 10.3.4 France
    • 10.3.5 Spain
    • 10.3.6 Rest of Europe
  • 10.4 Asia Pacific
    • 10.4.1 Japan
    • 10.4.2 China
    • 10.4.3 India
    • 10.4.4 Australia
    • 10.4.5 New Zealand
    • 10.4.6 South Korea
    • 10.4.7 Rest of Asia Pacific
  • 10.5 South America
    • 10.5.1 Argentina
    • 10.5.2 Brazil
    • 10.5.3 Chile
    • 10.5.4 Rest of South America
  • 10.6 Middle East & Africa
    • 10.6.1 Saudi Arabia
    • 10.6.2 UAE
    • 10.6.3 Qatar
    • 10.6.4 South Africa
    • 10.6.5 Rest of Middle East & Africa

11 Key Developments

  • 11.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 11.2 Acquisitions & Mergers
  • 11.3 New Product Launch
  • 11.4 Expansions
  • 11.5 Other Key Strategies

12 Company Profiling

  • 12.1 Teligent Pharma
  • 12.2 Almirall, S.A
  • 12.3 Perrigo Pharma
  • 12.4 Novartis AG
  • 12.5 Bayer AG
  • 12.6 Mylan
  • 12.7 Merck & Co
  • 12.8 LEO Pharma
  • 12.9 Johnson & Johnson
  • 12.10 Agile Therapeutics Inc.
  • 12.11 Cipla Ltd
  • 12.12 GlaxoSmithKline
  • 12.13 Encore Dermatology, Inc.
  • 12.14 Crescita Therapeutics Inc.
  • 12.15 Taro Pharmaceutical Industries Ltd
  • 12.16 Bausch Health Companies
  • 12.17 Glenmark Pharmaceuticals
  • 12.18 Aclaris Therapeutics, Inc.

List of Tables

  • Table 1 Global Topical Drug Delivery Market Outlook, By Region (2020-2028) ($MN)
  • Table 2 Global Topical Drug Delivery Market Outlook, By Route of Administration (2020-2028) ($MN)
  • Table 3 Global Topical Drug Delivery Market Outlook, By Vaginal Drug Delivery (2020-2028) ($MN)
  • Table 4 Global Topical Drug Delivery Market Outlook, By Rectal Drug Delivery (2020-2028) ($MN)
  • Table 5 Global Topical Drug Delivery Market Outlook, By Ophthalmic Drug Delivery (2020-2028) ($MN)
  • Table 6 Global Topical Drug Delivery Market Outlook, By Nasal Drug Delivery (2020-2028) ($MN)
  • Table 7 Global Topical Drug Delivery Market Outlook, By Dermal Drug Delivery (Skin) (2020-2028) ($MN)
  • Table 8 Global Topical Drug Delivery Market Outlook, By Product (2020-2028) ($MN)
  • Table 9 Global Topical Drug Delivery Market Outlook, By Liquid Formulations (2020-2028) ($MN)
  • Table 10 Global Topical Drug Delivery Market Outlook, By Suspensions (2020-2028) ($MN)
  • Table 11 Global Topical Drug Delivery Market Outlook, By Solutions (2020-2028) ($MN)
  • Table 12 Global Topical Drug Delivery Market Outlook, By Solid Formulations (2020-2028) ($MN)
  • Table 13 Global Topical Drug Delivery Market Outlook, By Suppositories (2020-2028) ($MN)
  • Table 14 Global Topical Drug Delivery Market Outlook, By Powders (2020-2028) ($MN)
  • Table 15 Global Topical Drug Delivery Market Outlook, By Devices (Transdermal Drug Delivery) (2020-2028) ($MN)
  • Table 16 Global Topical Drug Delivery Market Outlook, By Transdermal Semi-solids (2020-2028) ($MN)
  • Table 17 Global Topical Drug Delivery Market Outlook, By Transdermal Patches (2020-2028) ($MN)
  • Table 18 Global Topical Drug Delivery Market Outlook, By Inhaler (2020-2028) ($MN)
  • Table 19 Global Topical Drug Delivery Market Outlook, By Semi-Solid Formulations (2020-2028) ($MN)
  • Table 20 Global Topical Drug Delivery Market Outlook, By Pastes (2020-2028) ($MN)
  • Table 21 Global Topical Drug Delivery Market Outlook, By Ointments (2020-2028) ($MN)
  • Table 22 Global Topical Drug Delivery Market Outlook, By Lotions (2020-2028) ($MN)
  • Table 23 Global Topical Drug Delivery Market Outlook, By Gels (2020-2028) ($MN)
  • Table 24 Global Topical Drug Delivery Market Outlook, By Creams (2020-2028) ($MN)
  • Table 25 Global Topical Drug Delivery Market Outlook, By Distribution Channel (2020-2028) ($MN)
  • Table 26 Global Topical Drug Delivery Market Outlook, By Retail (2020-2028) ($MN)
  • Table 27 Global Topical Drug Delivery Market Outlook, By Offline (2020-2028) ($MN)
  • Table 28 Global Topical Drug Delivery Market Outlook, By Online (2020-2028) ($MN)
  • Table 29 Global Topical Drug Delivery Market Outlook, By Direct Tenders (2020-2028) ($MN)
  • Table 30 Global Topical Drug Delivery Market Outlook, By Facility of Use (2020-2028) ($MN)
  • Table 31 Global Topical Drug Delivery Market Outlook, By Hospitals & Private Clinics (2020-2028) ($MN)
  • Table 32 Global Topical Drug Delivery Market Outlook, By Home Care Settings (2020-2028) ($MN)
  • Table 33 Global Topical Drug Delivery Market Outlook, By Burn Centers (2020-2028) ($MN)
  • Table 34 Global Topical Drug Delivery Market Outlook, By Other Facilities (2020-2028) ($MN)
  • Table 35 Global Topical Drug Delivery Market Outlook, By Academic & Research Institutes (2020-2028) ($MN)
  • Table 36 Global Topical Drug Delivery Market Outlook, By Diagnostic Centers (2020-2028) ($MN)
  • Table 37 Global Topical Drug Delivery Market Outlook, By Type (2020-2028) ($MN)
  • Table 38 Global Topical Drug Delivery Market Outlook, By Hard & Rigid Braces (2020-2028) ($MN)
  • Table 39 Global Topical Drug Delivery Market Outlook, By Hinged Braces (2020-2028) ($MN)
  • Table 40 Global Topical Drug Delivery Market Outlook, By Soft & Elastic Braces (2020-2028) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.